Kura Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:KUR Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
28 Jan 25	Sell€16,350	Francis Burrows	Individual	2,166	€7.55
28 Jan 25	Sell€13,715	Kathleen Ford	Individual	1,817	€7.55
28 Jan 25	Sell€54,960	Teresa Bair	Individual	7,281	€7.55
28 Jan 25	Sell€37,463	Mollie Leoni	Individual	4,963	€7.55
28 Jan 25	Sell€37,357	Thomas Doyle	Individual	4,949	€7.55
28 Jan 25	Sell€11,949	Brian Powl	Individual	1,583	€7.55
18 Nov 24	Sell€7,979	Kathleen Ford	Individual	526	€15.17

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of KUR?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	691,471	0.799%
General Public	3,734,226	4.31%
Hedge Funds	21,765,388	25.1%
Institutions	60,383,602	69.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 76.55% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.45%	BlackRock, Inc.	8,177,476	€39.9m	3.07%	no data
8.96%	BVF Partners L.P.	7,754,129	€37.9m	202%	1.69%
8.59%	Suvretta Capital Management, LLC	7,439,259	€36.3m	46.5%	1.72%
7.59%	Armistice Capital LLC	6,572,000	€32.1m	13.3%	0.97%
5.72%	The Vanguard Group, Inc.	4,948,235	€24.2m	2.68%	no data
4.63%	RA Capital Management, L.P.	4,004,610	€19.6m	-10%	0.33%
3.79%	State Street Global Advisors, Inc.	3,282,080	€16.0m	-1.89%	no data
3.05%	EcoR1 Capital, LLC	2,640,298	€12.9m	-25.8%	0.82%
2.4%	Prosight Management, LP	2,078,315	€10.1m	56.9%	3.81%
2.09%	Millennium Management LLC	1,809,539	€8.8m	-23.6%	0.01%
2.08%	Geode Capital Management, LLC	1,802,559	€8.8m	1.15%	no data
1.82%	Morgan Stanley, Investment Banking and Brokerage Investments	1,574,244	€7.7m	-48.9%	no data
1.78%	Jacobs Levy Equity Management Inc	1,544,113	€7.5m	57.9%	0.03%
1.78%	Franklin Resources, Inc.	1,537,494	€7.5m	0.92%	no data
1.64%	TCG Crossover Management, LLC	1,423,642	€7.0m	0%	1.04%
1.57%	Dimensional Fund Advisors LP	1,362,424	€6.7m	-4.46%	no data
1.4%	HBM Partners Ltd.	1,210,000	€5.9m	0%	0.75%
1.36%	Qube Research & Technologies Ltd	1,173,125	€5.7m	5.14%	0.01%
1.28%	Foresite Capital Management, LLC	1,111,882	€5.4m	-35.6%	1.59%
1.11%	Algert Global LLC	958,492	€4.7m	8.46%	0.13%
1.06%	Assenagon Asset Management S.A.	919,079	€4.5m	1.54%	0.01%
0.91%	Sofinnova Investment, Inc.	791,667	€3.9m	0%	0.34%
0.86%	AQR Capital Management, LLC	746,174	€3.6m	399%	no data
0.84%	Goldman Sachs Group, Investment Banking and Securities Investments	726,170	€3.5m	-6.97%	no data
0.79%	Trexquant Investment LP	685,970	€3.3m	21%	0.04%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/29 07:12
End of Day Share Price	2025/05/29 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Kura Oncology, Inc. is covered by 20 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Peter Lawson	Barclays
Jason Zemansky	BofA Global Research
Leah Rush Cann	Brookline Capital Markets